Cargando…
Daunorubicin induced Stevens‐Johnson syndrome: A case report
Clinicians should consider the possible association of Daunorubicin with Stevens‐Johnson syndrome (SJS), administer it with caution and promptly evaluate all subsequently developing cutaneous reactions with a high index of suspicion for Stevens‐Johnson syndrome.
Autores principales: | Shakya, Preeti, Sharma Nepal, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283860/ https://www.ncbi.nlm.nih.gov/pubmed/34295492 http://dx.doi.org/10.1002/ccr3.4475 |
Ejemplares similares
-
Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report
por: Sharma, S. R., et al.
Publicado: (2011) -
Ivermectin induced Steven–Johnsons syndrome: case report
por: Aroke, Desmond, et al.
Publicado: (2017) -
Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021) -
Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report
por: Acharya, Ayushma, et al.
Publicado: (2020) -
Stevens-Johnson Syndrome Induced by Vandetanib
por: Yoon, Jimi, et al.
Publicado: (2011)